Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SANA

Sana Biotechnology Inc

May 05 • 04:00PM ET

3.49

+0.08 2.35 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: VERV PRME NTLA EDIT TSHA CRBU CABA BEAM MGTX PGEN

| Held by: XBI VTI IWM VXF IBB IWN SCHA VTWO PRFZ VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.98	Insider Own	37.81%	Shs Outstand	266.73M	Perf Week	4.18%
Market Cap	931.37M	Forward P/E	-	EPS next Y	-0.60	Insider Trans	0.00%	Shs Float	165.97M	Perf Month	8.39%
Enterprise Value	867.65M	PEG	-	EPS next Q	-0.16	Inst Own	47.48%	Short Float	24.63%	Perf Quarter	-20.86%
Income	-244.17M	P/S	-	EPS this Y	35.53%	Inst Trans	-3.10%	Short Ratio	13.93	Perf Half Y	-29.49%
Sales	0.00M	P/B	5.79	EPS next Y	3.05%	ROA	-52.64%	Short Interest	40.88M	Perf YTD	-14.25%
Book/sh	0.60	P/C	6.53	EPS next 5Y	14.10%	ROE	-118.70%	52W High	6.55 -46.72%	Perf Year	86.63%
Cash/sh	0.53	P/FCF	-	EPS past 3/5Y	12.33% 8.72%	ROIC	-108.61%	52W Low	1.60 118.12%	Perf 3Y	-38.77%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.06% 7.70%	Perf 5Y	-79.06%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	16.65%	Oper. Margin	-	ATR (14)	0.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.89	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.49	Recom	1.22
Dividend Gr. 3/5Y	- -	Current Ratio	1.89	EPS Q/Q	-2.65%	SMA20	2.95%	Beta	2.18	Target Price	8.57
Payout	-	Debt/Eq	0.49	Sales Q/Q	-	SMA50	3.63%	Rel Volume	0.55	Prev Close	3.41
Employees	142	LT Debt/Eq	0.40	Earnings	Mar 03 AMC	SMA200	-11.49%	Avg Volume	2.93M	Price	3.49
IPO	Feb 04, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-47.78% -	Trades		Volume	1,622,819	Change	2.35%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)